Nemluvio (nemolizumab-ilto)

Adult Dosing .

Dosage forms:  INJ (pen): 30 mg per injection

Special Note

[formulation clarification]

Info: nonproprietary name = nemolizumab-ilto

atopic dermatitis, moderate-severe

[30 mg SC q4wk]

Start: 60 mg SC x1, then 30 mg SC q4wk; Info: may decr. dose to 30 mg SC q8wk after 16wk

prurigo nodularis

[<90 kg]

Dose: 30 mg SC q4wk; Start: 60 mg SC x1, then 30 mg SC q4wk

[>90 kg]

Dose: 60 mg SC q4wk

renal dosing

[see below]

mild-moderate impairment: no adjustment; severe impairment: not defined

HD/PD: not defined

hepatic dosing

[see below]

mild-moderate impairment: no adjustment; severe impairment: not defined

Peds Dosing .

Dosage forms:  INJ (pen): 30 mg per injection

Special Note

[formulation clarification]

Info: nonproprietary name = nemolizumab-ilto

atopic dermatitis, moderate-severe

[12 yo and older]

Dose: 30 mg SC q4wk; Start: 60 mg SC x1, then 30 mg SC q4wk; Info: may decr. dose to 30 mg SC q8wk after 16wk

renal dosing

[see below]

mild-moderate impairment: no adjustment; severe impairment: not defined

HD/PD: not defined

hepatic dosing

[see below]

mild-moderate impairment: no adjustment; severe impairment: not defined